The headlines regarding Magda Szubanski’s health follow a script so predictable it’s a wonder the press doesn't just use a Mad Libs template. "In Remission." "The Battle Won." "A Miracle Recovery." It’s an easy, comforting narrative that sells magazines and drives clicks by painting a picture of a finish line.
But there is no finish line in oncology.
By treating remission as a permanent victory, the media does a profound disservice to the millions of people living with chronic illness. They trade medical reality for a feel-good story that leaves the public fundamentally ignorant of how cancer actually works. I’ve seen this cycle play out for decades in the industry: a beloved figure gets sick, the public enters a state of collective mourning, a "clear" scan is reported, and everyone breathes a sigh of relief as if the threat has been vaporized.
It hasn’t. We need to stop treating remission like a trophy and start seeing it for what it is: a tactical pause in a lifelong engagement.
The Semantic Trap of Remission
Most people hear "remission" and think "cured." They are wrong.
In clinical terms, remission—specifically Complete Remission (CR)—means that signs and symptoms of cancer have disappeared and the disease is undetectable by current imaging and blood tests. However, the threshold for "undetectable" is not zero. A patient can have millions of malignant cells still circulating in their system, hidden in the bone marrow or lymph nodes, below the sensitivity level of a PET or CT scan.
To say someone is "in remission" is a statement about the current limitations of our diagnostic equipment, not a guarantee of biological eradication. When the media ignores this nuance, they set up an inevitable "tragedy" narrative if the cancer returns. In reality, recurrence isn't always a tragedy; it’s often the expected biological progression of the disease that was never truly gone.
The Problem with "Battle" Imagery
We love to say celebrities "fought" cancer. This implies that those who don't reach remission simply didn't fight hard enough. It suggests that survival is a matter of willpower, grit, and a "positive attitude."
This is offensive nonsense.
Biology doesn't care about your bravery. The cells divide based on genetic mutations, protein signaling, and metabolic pathways—not your desire to see another sunset. By framing Magda Szubanski’s health status as a personal victory of her spirit, we hide the cold, hard truth: health outcomes are largely a lottery of genetics, access to $150,000-a-year immunotherapy drugs, and the specific molecular subtype of the tumor.
When we celebrate the "win," we inadvertently shame the "losers" who are still in the trenches or whose bodies didn't respond to the same protocols.
The Economics of the "Recovery" Story
The press isn't just being lazy; they are being profitable. A recovery story has a much higher CPM (Cost Per Mille) than a story about the grueling, boring, and expensive reality of maintenance therapy.
- The Hook: The initial diagnosis generates fear and empathy.
- The Middle: Updates on treatment create a "journey" for the audience to follow.
- The Payoff: The remission announcement provides emotional closure.
The problem is that real health doesn't have closure. For a high-profile figure like Szubanski, being in remission often involves years of follow-up scans, bone-thinning hormonal therapies, and the crushing "scanxiety" that precedes every check-up. The media ignores this because "Magda Szubanski Spends Three Hours in a Waiting Room for a Routine Blood Draw" doesn't get shared on Facebook.
By skipping the maintenance phase, we create a society that expects people to be "back to normal" the moment the chemo ends. We deny survivors the right to be tired, traumatized, or physically diminished.
Maintenance is the New Cure
We are moving into an era where many cancers are treated as chronic manageable conditions rather than acute terminal illnesses. This is a massive shift in the medical $paradigm$—oops, I mean the medical framework.
Consider the use of Tyrosine Kinase Inhibitors (TKIs) or long-term PARP inhibitors. These drugs don't "kill" the cancer in the traditional sense; they keep it asleep. A patient might be in remission for ten years while taking a daily pill that causes chronic nausea and fatigue.
Are they "better"? Technically, yes. Are they "cured"? No.
Magda Szubanski’s situation should be used to highlight the brilliance of modern maintenance medicine, not to peddle a fairy tale about a miraculous exit from the world of the sick. When we focus on the "miracle," we fail to fund the "mundane"—the social support systems, the workplace protections for those with chronic conditions, and the mental health resources required for long-term survivors.
The False Promise of "Clear"
I’ve sat in rooms with stakeholders who want to use celebrity health stories to "inspire" the public. They want a clean arc. But real life is messy.
Imagine a scenario where a celebrity announces they are cancer-free, only to have a recurrence six months later. The public reaction is one of shock and betrayal. "But she was cured!" No, she was just under the detection limit. If we were honest from day one, the recurrence wouldn't be a shock; it would be a known risk that was being actively managed.
We have a duty to be brutally honest about the following:
- Residual Disease: The "minimal residual disease" (MRD) is the real enemy.
- Late Effects: Radiation and chemo don't just leave the body; they leave permanent scars on the heart, lungs, and cognitive function.
- Financial Toxicity: Even for celebrities, the cost of staying in remission is astronomical. For the average Australian or American, "remission" can still mean bankruptcy.
Stop Asking "Is She Okay?"
The most common question people ask about Szubanski or any public figure in her position is, "Is she okay now?"
It's the wrong question. It demands a binary "yes" or "no" in a world that exists entirely in shades of gray. The right question is: "What does her quality of life look like during this period of remission, and how is she being supported?"
By demanding a "yes," we force public figures to put on a mask of health even when they are struggling. We see them on talk shows looking radiant, unaware of the makeup covering the pallor or the exhaustion they’ll feel for a week afterward. We are complicit in a performance of health that makes actual sick people feel like failures for not "bouncing back" with the same grace.
The Brutal Truth of the Spotlight
Celebrities like Szubanski are often forced to become avatars for our own fears of mortality. When they "beat" cancer, we feel like we might beat it too. It’s a proxy war against death.
But this projection is dangerous. It leads to a culture where we over-screen, over-treat, and over-promise. We chase the "clear" scan at all costs, sometimes at the expense of the patient’s actual well-being.
Remission is a gift of time. It is a reprieve. It is a beautiful, hard-won period of relative stability. But it is not a "victory" over a defeated foe. The foe is still there, lurking in the shadows of the DNA, waiting for a chance to replicate.
If we want to actually support people with cancer, we have to stop cheering for the "end" of their journey and start acknowledging the permanent reality of their new life.
Stop looking for a happy ending. Start looking for the truth of the middle. The celebration of Magda’s remission shouldn't be a closing chapter; it should be an opening for a much more difficult conversation about the reality of survivorship that the media is too cowardly to have.
The cancer isn't gone. It's just waiting. And we need to be okay with that.
